Avidity Biosciences, Inc. — Director's Dealing 2023

Dec 14, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Avidity Biosciences, Inc. (RNA)
CIK: 0001599901
Period of Report: 2023-12-12

Reporting Person: WILSON TROY EDWARD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-12	Common Stock	J	300000	—	Disposed	263711	Indirect
2023-12-12	Common Stock	J	300000	—	Acquired	300000	Indirect
2023-12-12	Common Stock	J	250000	—	Disposed	13711	Indirect
2023-12-12	Common Stock	J	250000	—	Acquired	300000	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	35553	Indirect
Common Stock	35553	Indirect
Common Stock	11851	Indirect
Common Stock	11851	Indirect
Common Stock	62733	Direct

Footnotes

F1: Represents a transfer for no value from the Reporting Person to a trust established for the benefit of the Reporting Person's family.